Cambridge Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.74M | Buy |
19,936
+813
| +4% | +$69.4K | 0.07% | 119 |
|
|
2023
Q4 | $1.58M | Sell |
19,123
-5,541
| -22% | -$422K | 0.07% | 123 |
|
|
2023
Q3 | $1.93M | Buy |
24,664
+3,985
| +19% | +$334K | 0.09% | 112 |
|
|
2023
Q2 | $1.82M | Sell |
20,679
-3,029
| -13% | -$261K | 0.08% | 111 |
|
|
2023
Q1 | $1.91M | Sell |
23,708
-16,895
| -42% | -$1.38M | 0.09% | 110 |
|
|
2022
Q4 | $3.16M | Sell |
40,603
-175,202
| -81% | -$14.2M | 0.14% | 96 |
|
|
2022
Q3 | $17.4M | Sell |
215,805
-3,372
| -2% | -$303K | 0.83% | 47 |
|
|
2022
Q2 | $19.7M | Sell |
219,177
-929
| -0.4% | -$94.1K | 0.86% | 44 |
|
|
2022
Q1 | $24.4M | Buy |
220,106
+739
| +0.3% | +$78.1K | 0.86% | 40 |
|
|
2021
Q4 | $22.7M | Sell |
219,367
-4,714
| -2% | -$546K | 0.73% | 50 |
|
|
2021
Q3 | $28.1M | Sell |
224,081
-1,840
| -0.8% | -$238K | 1.06% | 35 |
|
|
2021
Q2 | $28M | Sell |
225,921
-979
| -0.4% | -$123K | 1.06% | 32 |
|
|
2021
Q1 | $26.8M | Buy |
226,900
+4,227
| +2% | +$495K | 1.09% | 36 |
|
|
2020
Q4 | $26.1M | Sell |
222,673
-1,087
| -0.5% | -$120K | 1.24% | 36 |
|
|
2020
Q3 | $23.3M | Sell |
223,760
-1,386
| -0.6% | -$139K | 1.2% | 32 |
|
|
2020
Q2 | $21.7M | Sell |
225,146
-35,864
| -14% | -$3.44M | 1.14% | 34 |
|
|
2020
Q1 | $23.5M | Buy |
261,010
+3,305
| +1% | +$352K | 1.62% | 19 |
|
|
2019
Q4 | $29.2M | Buy |
257,705
+970
| +0.4% | +$106K | 1.55% | 20 |
|
|
2019
Q3 | $27.9M | Sell |
256,735
-1,017
| -0.4% | -$106K | 1.62% | 18 |
|
|
2019
Q2 | $25.1M | Sell |
257,752
-2,468
| -0.9% | -$225K | 1.46% | 22 |
|
|
2019
Q1 | $23.7M | Buy |
260,220
+1,257
| +0.5% | +$113K | 1.42% | 26 |
|
|
2018
Q4 | $23.6M | Sell |
258,963
-2,673
| -1% | -$250K | 1.62% | 22 |
|
|
2018
Q3 | $25.7M | Sell |
261,636
-331
| -0.1% | -$30.6K | 1.48% | 20 |
|
|
2018
Q2 | $22.4M | Sell |
261,967
-723
| -0.3% | -$60.4K | 1.39% | 22 |
|
|
2018
Q1 | $21.1M | Sell |
262,690
-1,672
| -0.6% | -$138K | 1.34% | 26 |
|
|
2017
Q4 | $21.3M | Sell |
264,362
-3,830
| -1% | -$307K | 1.35% | 27 |
|
|
2017
Q3 | $20.9M | Sell |
268,192
-2,958
| -1% | -$246K | 1.4% | 25 |
|
|
2017
Q2 | $24.1M | Buy |
271,150
+3,723
| +1% | +$314K | 1.66% | 16 |
|
|
2017
Q1 | $21.5M | Sell |
267,427
-51,210
| -16% | -$4M | 1.43% | 23 |
|
|
2016
Q4 | $22.7M | Sell |
318,637
-42,747
| -12% | -$3.36M | 1.6% | 17 |
|
|
2016
Q3 | $31.2M | Buy |
361,384
+7,117
| +2% | +$620K | 2.28% | 8 |
|
|
2016
Q2 | $30.7M | Buy |
354,267
+5,222
| +1% | +$422K | 2.35% | 4 |
|
|
2016
Q1 | $26.2M | Buy |
349,045
+1,878
| +0.5% | +$141K | 2.15% | 8 |
|
|
2015
Q4 | $26.7M | Buy |
347,167
+3,221
| +0.9% | +$242K | 2.19% | 8 |
|
|
2015
Q3 | $23M | Buy |
343,946
+4,323
| +1% | +$318K | 2.02% | 9 |
|
|
2015
Q2 | $25.2M | Buy |
339,623
+16,785
| +5% | +$1.28M | 2.08% | 10 |
|
|
2015
Q1 | $25.2M | Buy |
322,838
+82,000
| +34% | +$6.22M | 2.12% | 7 |
|
|
2014
Q4 | $17.4M | Buy |
240,838
+79,286
| +49% | +$5.51M | 1.51% | 26 |
|
|
2014
Q3 | $10M | Buy |
161,552
+157,972
| +4,413% | +$10M | 0.89% | 45 |
|
|
2014
Q2 | $228K | Buy |
+3,580
| New | +$217K | 0.02% | 189 |
|
Other funds holding MDT
Cambridge Trust's MDT Position: Q1 2024 in Review
Cambridge Trust increased its Medtronic (MDT) stake by 4.3% in Q1 2024, buying an estimated $69.4K and bringing the position to 19,936 shares worth $1.74M. The position accounts for 0.07% of the portfolio, ranked #119.
Cambridge Trust first reported a position in MDT in Q2 2014 and has held it in 40 quarters since. The position peaked at $31.2M in Q3 2016. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Cambridge Trust held 19,936 shares of Medtronic worth $1.74M as of Q1 2024.
- Cambridge Trust bought 813 Medtronic shares in Q1 2024, an estimated $69.4K.
- Medtronic made up 0.07% of Cambridge Trust's portfolio in Q1 2024, its #119 holding.
- Cambridge Trust first reported a position in Medtronic in Q2 2014 and has held it in 40 quarters since.
- Cambridge Trust's Medtronic position peaked at $31.2M in Q3 2016.
- 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.